About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Pharmacology Review of Medications in the Cardiac Cath Lab
By
ARCH Advanced Revascularization Symposium
By
ARCH Advanced Revascularization Symposium
35 views
May 27, 2019
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
14:39
Lankenau
Management of AF patients with ACS
Feat.
P. Kowey,
D. Ice
15:40
ACC 2022 Conference Coverage
ACC 2022: Triple Therapy - When to Use and How Long
Feat.
D. Kumbhani
57:30
McMaster University Department of Medicine
Five Things Every Internist Should Know About Anticoagulants
Feat.
S. Mithoowani
31:10
Insights from 2024 ACP Annual Meeting
ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …
Feat.
D. Berg
21:51
Cedars Sinai
Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…
Feat.
W. Boden
14:44
26th Annual San Diego Heart Failure Symposium
Broadening Indications for the Use of Angiotensin Receptor Neprilysi…
Feat.
C. Yancy
19:47
Complex Coronary Cases
Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…
Feat.
U. Baber
34:40
Icahn School of Medicine at Mount Sinai
Peri-Operative Management of Anticoagulation
Feat.
A. Dunn
15:41
UCLA Health
Anticoagulation in ECLS - To Bleed, or Not to Clot...
Feat.
A. Young
20:50
Salim Virani
Aspirin for Primary Prevention
33:50
Houston Methodist DeBakey Heart and Vascular Center
Left Ventricular Thrombosis: An Overview
Feat.
Y. Saleh
20:59
Scripps Health: 2019 Sixth Annual Clinical Advances in Heart Failure and Arrhythmias
What’s New in Heart Failure Guidelines? Beyond Beta Blockers, Ace In…
Feat.
T. Heywood
20:06
Canadian Collaborative Research Network
Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?
Feat.
M. Sabatine
12:46
AHA 2022 Conference Coverage
AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Com…
Feat.
F. Bakaeen
14:00
ACC 2024 Insights
ACC 2024 Insights: De-Escalation After ACS - Which Patient, When and…
Feat.
F. Franchi
15:13
Cardiometabolic Health Congress (CMHC)
Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…
Feat.
D. Bhatt
16:34
AHA 2022 Conference Coverage
AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Hepa…
Feat.
G. W. Stone
11:50
TCT 2023 Insights
TCT 2023 Insights: Where Do Antithrombotics Fit In?
Feat.
M. Bonaca
12:53
Scottsdale Interventional Forum 2018
What is the Optimal DAPT Duration?
Feat.
R. Yeh
45:37
Cedars Sinai
Eliquis: Alternative Anticoagulation for HeartMate 3 Ventricular Ass…
Feat.
M. Slaughter
